Pomerantz Law Firm Announces the Filing of a Class Action against MEI Pharma, Inc. and Certain Officers – MEIP

NEW YORK, Aug. 10, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against MEI Pharma, Inc. (“MEI” or the “Company”) (NASDAQ: MEIP) and certain of its officers.   The class action, filed in United States District Court for the Southern District of California, and docketed under 20-cv-01543, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired MEI Pharma securities between August 2, 2017, and July 1, 20…

Click here to view the original article.